Clinical and patient-reported outcome measures included: the hidradenitis suppurativa-physician global assessment (HS-PGA = 4/severe), the numerical rating scale for pain (NRS-pain 7/10), the dermatology-life quality index (DLQI = 23), and C-reactive protein (CRP 4.8 mg/dl) (Fig. 1A and B). The gene discussed is CRP; the disease is hidradenitis suppurativa.